Sieper, J <br/><br/>
Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Dec 2005 
 - 1525-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0324 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kei046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infliximab<br/>Magnetic Resonance Imaging--methods<br/>Male<br/>Middle Aged<br/>Severity of Illness Index<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors